Cara Therapeutics, Inc. (0HTC.L)

USD 0.25

(-1.15%)

Eps Summary of Cara Therapeutics, Inc.

  • Cara Therapeutics, Inc.'s latest annual eps in 2023 was -2.19 USD , down -41.29% from previous year.
  • Cara Therapeutics, Inc.'s latest quarterly eps in 2024 Q2 was -0.37 USD , up 33.93% from previous quarter.
  • Cara Therapeutics, Inc. reported an annual eps of -1.55 USD in 2022, up 10.92% from previous year.
  • Cara Therapeutics, Inc. reported an annual eps of -1.74 USD in 2021, down -1066.67% from previous year.
  • Cara Therapeutics, Inc. reported a quarterly eps of -0.56 USD for 2024 Q1, up 5.08% from previous quarter.
  • Cara Therapeutics, Inc. reported a quarterly eps of -0.52 USD for 2023 Q3, up 10.34% from previous quarter.

Annual Eps Chart of Cara Therapeutics, Inc. (2023 - 2011)

Historical Annual Eps of Cara Therapeutics, Inc. (2023 - 2011)

Year Eps Eps Growth
2023 -2.19 USD -41.29%
2022 -1.55 USD 10.92%
2021 -1.74 USD -1066.67%
2020 0.18 USD 107.23%
2019 -2.49 USD -20.87%
2018 -2.06 USD -10.75%
2017 -1.86 USD 11.43%
2016 -2.10 USD -110.0%
2015 -1.00 USD -17.65%
2014 -0.85 USD -372.22%
2013 -0.18 USD 82.18%
2012 -1.01 USD 36.48%
2011 -1.59 USD 0.0%

Peer Eps Comparison of Cara Therapeutics, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD -8.416%
Dynavax Technologies Corporation -0.05 USD -4315.323%
Supernus Pharmaceuticals, Inc. 0.02 USD 9187.137%
Perrigo Company plc -0.09 USD -2232.268%
Illumina, Inc. -7.35 USD 70.204%
Thermo Fisher Scientific Inc. 15.53 USD 114.102%
Iovance Biotherapeutics, Inc. -1.89 USD -15.873%
Walgreens Boots Alliance, Inc. -10.01 USD 78.122%
IQVIA Holdings Inc. 7.39 USD 129.635%
Heron Therapeutics, Inc. -0.80 USD -173.75%
Regeneron Pharmaceuticals, Inc. 37.05 USD 105.911%
Unity Biotechnology, Inc. -2.70 USD 18.889%
Waters Corporation 10.87 USD 120.147%
Biogen Inc. 8.02 USD 127.307%
Sangamo Therapeutics, Inc. -1.48 USD -47.973%
Evolus, Inc. -1.08 USD -102.778%
Adicet Bio, Inc. -3.31 USD 33.837%
bluebird bio, Inc. -1.93 USD -13.472%
Esperion Therapeutics, Inc. -2.03 USD -7.882%
FibroGen, Inc. -2.92 USD 25.0%
Agilent Technologies, Inc. 4.22 USD 151.896%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 78.758%
Homology Medicines, Inc. -7.41 USD 70.445%
Geron Corporation -0.32 USD -584.375%
Alnylam Pharmaceuticals, Inc. -3.52 USD 37.784%
Amicus Therapeutics, Inc. -0.51 USD -329.412%
Myriad Genetics, Inc. -1.39 USD -57.554%
Viking Therapeutics, Inc. -0.91 USD -140.659%
Intellia Therapeutics, Inc. -5.42 USD 59.594%
Zoetis Inc. 5.08 USD 143.11%
Abeona Therapeutics Inc. -2.53 USD 13.439%
Mettler-Toledo International Inc. 36.10 USD 106.066%
BioMarin Pharmaceutical Inc. 0.89 USD 346.067%
Vertex Pharmaceuticals Incorporated 14.05 USD 115.587%
Kala Pharmaceuticals, Inc. -17.35 USD 87.378%
Ionis Pharmaceuticals, Inc. -2.56 USD 14.453%
Atara Biotherapeutics, Inc. -65.18 USD 96.64%
Verastem, Inc. -3.96 USD 44.697%
Nektar Therapeutics -1.45 USD -51.034%
Axsome Therapeutics, Inc. -5.27 USD 58.444%
Aclaris Therapeutics, Inc. -1.27 USD -72.441%
Sarepta Therapeutics, Inc. -5.80 USD 62.241%
OPKO Health, Inc. -0.25 USD -776.0%
Exelixis, Inc. 0.65 USD 436.923%
Neurocrine Biosciences, Inc. 2.56 USD 185.547%
Corcept Therapeutics Incorporated 1.02 USD 314.706%
Anavex Life Sciences Corp. -0.60 USD -265.0%
uniQure N.V. -6.47 USD 66.151%
Imunon, Inc. -2.16 USD -1.389%
Blueprint Medicines Corporation -8.37 USD 73.835%
Insmed Incorporated -5.34 USD 58.989%
Halozyme Therapeutics, Inc. 2.13 USD 202.817%
Agios Pharmaceuticals, Inc. -6.33 USD 65.403%
TG Therapeutics, Inc. 0.09 USD 2552.408%
Incyte Corporation 2.67 USD 182.022%
Emergent BioSolutions Inc. -14.85 USD 85.253%